Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.5 USD | -0.46% |
|
-1.37% | -65.15% |
06-25 | Guggenheim Downgrades 10x Genomics to Neutral From Buy | MT |
06-03 | Jefferies Initiates 10x Genomics at Hold Rating With $24 Price Target | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- TXG Stock
- Revisions 10x Genomics, Inc.